🇺🇸 FDA

Drug profile · INN

entrectinib

ROZLYTREK

approved L01EX14
US status
approved
Patents linked
0
News articles
1

Quick answer

entrectinib (ROZLYTREK) is an FDA-listed pharmaceutical active ingredient. Associated with Hoffmann-La Roche. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN entrectinib
Brand ROZLYTREK
Route ORAL
Formulation CAPSULE
ATC code L01EX14
Originator Hoffmann-La Roche

Frequently asked questions

What is entrectinib?

entrectinib (ROZLYTREK) is an FDA-listed pharmaceutical active ingredient. Associated with Hoffmann-La Roche. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for entrectinib?

ROZLYTREK is a marketed brand name for entrectinib. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of entrectinib?

entrectinib has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.